Toxicity studies of tosufloxacin tosilate hydrate in juvenile animals and class effects studies

Japanese Journal of Chemotherapy

Volumn 58, Issue SUPPL. 2, 2010, Pages 12-23

  Furubo, Shinichi ^a   Fukuda, Hitoshi ^a   Kozaki, Tsukasa ^a   Akune, Atsushi ^b   Sanzen, Takahiro ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

Adverse effect; Juvenile animal; Tosufloxacin

Indexed keywords

CIPROFLOXACIN; GLUCOSE; INSULIN; NORFLOXACIN; TOSUFLOXACIN TOSILATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DOG; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; KIDNEY TUBULE; MALE; NONHUMAN; QT INTERVAL; RAT; WEIGHT GAIN;

EID: 78649421812     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T: In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 1997; 41: 1331-4
2. Felmingham D, Reinert R R, Hirakata Y, Rodloff A: Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002; 50: 25-37
3. Nariai A: Prevalence of β-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae and Haemophilus influenzae type b strains obtained from children with lower respiratory tract infections. J Infect Chemother 2007; 13: 396-9
4. rd ed. Academic Press, San Diego. 2000; p. 397-453
5. Ball P: Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. J Antimicrob Chemother 2000; 45: 557-9
6. Kang J, Wang L, Chen X L, Triggle D J, Rampe D: Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol 2001; 59: 122-6
7. Fridericia L S: Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920; 53: 469-86
8. Chemotherapy 1988; 36: 233-49
9. Machida M, Kusajima H, Aijima H, Maeda A, Ishida R, Uchida H: Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 1990; 105: 403-12
10. Nagai A, Miyazaki M, Morita T, Furubo S, Kizawa K, Fukumoto H, et al: Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs. J Toxicol Sci 2002; 27: 219-28
11. Chemotherapy 1988; 36: 343-69
12. Maeda N, Tamagawa T, Niki I, Miura H, Ozawa K, Watanabe G, et al: Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996; 117: 372-6
13. Chemotherapy 1988; 36: 250-93